MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Max Drawdown (5Y): 100.0% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.0% |
| September 30, 2024 | 100.0% |
| August 31, 2024 | 100.0% |
| July 31, 2024 | 100.0% |
| June 30, 2024 | 100.0% |
| May 31, 2024 | 100.0% |
| April 30, 2024 | 100.0% |
| March 31, 2024 | 100.0% |
| February 29, 2024 | 100.0% |
| January 31, 2024 | 100.0% |
| December 31, 2023 | 100.0% |
| November 30, 2023 | 100.0% |
| October 31, 2023 | 100.0% |
| September 30, 2023 | 100.0% |
| August 31, 2023 | 100.0% |
| July 31, 2023 | 100.0% |
| June 30, 2023 | 100.0% |
| May 31, 2023 | 100.0% |
| April 30, 2023 | 100.0% |
| March 31, 2023 | 100.0% |
| February 28, 2023 | 100.0% |
| January 31, 2023 | 100.0% |
| December 31, 2022 | 100.0% |
| November 30, 2022 | 100.0% |
| October 31, 2022 | 100.0% |
| Date | Value |
|---|---|
| September 30, 2022 | 100.0% |
| August 31, 2022 | 100.0% |
| July 31, 2022 | 89.95% |
| June 30, 2022 | 89.95% |
| May 31, 2022 | 89.51% |
| April 30, 2022 | 89.51% |
| March 31, 2022 | 89.51% |
| February 28, 2022 | 89.51% |
| January 31, 2022 | 89.51% |
| December 31, 2021 | 89.51% |
| November 30, 2021 | 89.51% |
| October 31, 2021 | 89.51% |
| September 30, 2021 | 89.51% |
| August 31, 2021 | 89.51% |
| July 31, 2021 | 89.51% |
| June 30, 2021 | 89.51% |
| May 31, 2021 | 89.51% |
| April 30, 2021 | 89.51% |
| March 31, 2021 | 89.51% |
| February 28, 2021 | 89.51% |
| January 31, 2021 | 89.51% |
| December 31, 2020 | 89.51% |
| November 30, 2020 | 89.51% |
| October 31, 2020 | 89.51% |
| September 30, 2020 | 89.51% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.68%
Minimum
Nov 2019
100.0%
Maximum
Aug 2022
93.85%
Average
89.51%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Galapagos NV | 91.17% |
| UCB SA | 50.06% |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | -- |
| Celyad Oncology SA | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.072M |
| Beta (5Y) | -392910.5 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 25.99M% |
| Historical Sortino (5Y) | -0.3686 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.31% |